Nathan Robert Augspurger is a notable inventor based in Noblesville, IN (US). He has made significant contributions to the field of microbial technology, holding a total of 7 patents. His work primarily focuses on the development of microbial strains for various applications, including virus inhibition and animal health.

Latest Patents

Among his latest patents, one notable invention is related to microbial strains for virus inhibition. This invention encompasses compositions comprising isolated strains selected from a specific group, aimed at inhibiting viruses. The strains include 300, 86, 101, 235, 102, 177, A12, 54, 681, and 721, along with methods for their application in virus inhibition. Another significant patent involves direct-fed microbials intended for use in animals. This invention details isolated strains 101, 235, 77, 177, and 102, which can also be utilized for treating plants and in food processing.

Career Highlights

Throughout his career, Nathan has worked with several companies, including Microbial Discovery Group, LLC and United Animal Health, Inc. His expertise in microbial technology has positioned him as a key player in the industry, contributing to advancements in health and agriculture.

Collaborations

Nathan has collaborated with notable individuals in his field, including Michael R. King and Sona Son. These partnerships have further enhanced his research and development efforts.

Conclusion

Nathan Robert Augspurger is a distinguished inventor whose work in microbial technology has led to innovative solutions for virus inhibition and animal health. His contributions continue to impact various sectors, showcasing the importance of innovation in science and technology.

This text is generated by artificial intelligence and may not be accurate.